Tranexamic acid for anaemia in women
Treatments studied
Part of Blood & lymphatic, Hormones & metabolism clinical trials.
This trial tests whether tranexamic acid, a medicine that helps reduce bleeding, can improve anaemia (low blood iron) in women with heavy periods. If you have anaemia and heavy menstrual bleeding, this treatment might help raise your iron levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 or older.
- You must be currently having periods that come at least every 38 days and last at least 2 days.
- You must have anaemia (low blood iron), confirmed by a finger-prick test at screening.
- You must not be planning to get pregnant during the trial.
- You must not be currently taking tranexamic acid, and you must not have conditions that make this drug unsafe (like blood clots, kidney problems, or a history of seizures).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a medicine called tranexamic acid can safely reduce heavy bleeding during periods for people who are taking blood thinners for a recent blood clot. It is a pilot study to see if a larger trial is possible.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can prevent heavy bleeding after delivery in women who are at higher risk. If it works, it may lower the chance of serious postpartum bleeding and related complications.
This trial tests if a medicine called tranexamic acid can reduce the risk of heavy bleeding after a C-section for women who have certain autoimmune diseases. It aims to help prevent postpartum hemorrhage in this specific group.
This trial tests whether a medicine called tranexamic acid can help reduce the need for blood transfusions during major abdominal surgeries. It's for people having surgery to remove part of the esophagus, stomach, colon, rectum, pancreas, or liver.
This trial is testing if a medicine called tranexamic acid (TXA) can help reduce bleeding during a second-trimester abortion or miscarriage procedure. The goal is to make the procedure safer for patients.
This trial tests if tranexamic acid, a medicine that helps blood clot, can reduce bleeding in people with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) who have very low platelet counts and are receiving less-intensive chemotherapy.
Hear when a new Anaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.